4//SEC Filing
HANSON GREGORY P 4
Accession 0001415889-17-001619
CIK 0001109196other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:25 AM ET
Size
5.9 KB
Accession
0001415889-17-001619
Insider Transaction Report
Form 4
HANSON GREGORY P
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit
2017-10-02+340,420→ 340,420 total→ Common Stock (340,420 underlying)
Footnotes (1)
- [F1]Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186120
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 6:25 AM ET
- Size
- 5.9 KB